Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -39.20% is 401% below its 5-year average of -7.83%, around the middle of its 5-year range (-239.94%–47.88%).
1.07% below its 12-month average of -38.79%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-28): -14.72%.
NET PROFIT MARGIN
-39.20%
NET PROFIT MARGIN AVG TTM
-38.79%
NET PROFIT MARGIN AVG 3Y
-13.72%
NET PROFIT MARGIN AVG 5Y
-7.83%
NET PROFIT MARGIN AVG 10Y
6.96%
NET PROFIT MARGIN AVG 15Y
1.78%
NET PROFIT MARGIN AVG 20Y
3.72%
CURRENT VS TTM AVG
-1.07%
CURRENT VS 3Y AVG
-185.70%
CURRENT VS 5Y AVG
-400.76%
CURRENT VS 10Y AVG
-662.99%
CURRENT VS 15Y AVG
-2299.80%
CURRENT VS 20Y AVG
-1154.84%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-14976.92%
vs the sector median at left
QuidelOrtho Corporation
Market Cap
$846.74M
Net Profit Margin
-39.20%
TTM Avg
-38.79%
3Y Avg
-13.72%
5Y Avg
-7.83%
Market Cap
$849.50M
Net Profit Margin
-82.49%
TTM Avg
-271.33%
3Y Avg
-235.13%
5Y Avg
-173.69%
Market Cap
$840.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$840.86M
Net Profit Margin
-61.32%
TTM Avg
-78.55%
3Y Avg
-9174.62%
5Y Avg
-9174.62%
Market Cap
$838.44M
Net Profit Margin
-5933.45%
TTM Avg
-505.88%
3Y Avg
-252.94%
5Y Avg
-252.94%
Market Cap
$856.66M
Net Profit Margin
-6.85%
TTM Avg
-13.95%
3Y Avg
-29.17%
5Y Avg
-39.83%
Market Cap
$857.96M
Net Profit Margin
-173.85%
TTM Avg
-104.63%
3Y Avg
-54.62%
5Y Avg
-54.62%
Market Cap
$834.27M
Net Profit Margin
-560.85%
TTM Avg
-63.69%
3Y Avg
-31.84%
5Y Avg
-21.23%
Market Cap
$863.59M
Net Profit Margin
116.30%
TTM Avg
67.23%
3Y Avg
16.07%
5Y Avg
4.15%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QuidelOrtho Corporation (QDEL) | $846.74M | -39.20% | -38.79% | -13.72% | -7.83% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $849.50M | -82.49% | -271.33% | -235.13% | -173.69% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $840.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Beta Bionics, Inc. (BBNX)vs › | $840.86M | -61.32% | -78.55% | -9174.62% | -9174.62% |
| Alumis Inc. (ALMS)vs › | $838.44M | -5933.45% | -505.88% | -252.94% | -252.94% |
| SI-BONE, Inc. (SIBN)vs › | $856.66M | -6.85% | -13.95% | -29.17% | -39.83% |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | -173.85% | -104.63% | -54.62% | -54.62% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $834.27M | -560.85% | -63.69% | -31.84% | -21.23% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.59M | 116.30% | 67.23% | 16.07% | 4.15% |
| Ardelyx, Inc. (ARDX)vs › | $812.73M | -12.35% | -13.43% | -52.20% | -503.49% |
Operating Margin
-30.7%
Net Profit Margin
-39.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-28 | -14.72% |
| 2026-03-29 | -14.81% |
| 2025-12-28 | -18.06% |
| 2025-09-28 | -104.73% |
| 2025-06-29 | -41.60% |
| 2025-03-30 | -1.83% |
| 2024-12-29 | -25.20% |
| 2024-09-29 | -2.74% |
| 2024-06-30 | -23.19% |
| 2024-03-31 | -239.94% |
| 2023-12-31 | 0.94% |
| 2023-10-01 | -1.71% |
| 2023-07-02 | -8.00% |
| 2023-04-02 | 5.77% |
| 2023-01-01 | 3.50% |
| 2022-10-02 | 2.45% |
| 2022-07-03 | 3.15% |
| 2022-03-31 | 47.88% |
| 2021-12-31 | 45.74% |
| 2021-09-30 | 42.31% |
| 2021-06-30 | 10.82% |
| 2021-03-31 | 47.45% |
| 2020-12-31 | 58.10% |
| 2020-09-30 | 48.79% |
| 2020-06-30 | 33.53% |
| 2020-03-31 | 23.04% |
| 2019-12-31 | 20.13% |
| 2019-09-30 | 12.79% |
| 2019-06-30 | 1.17% |
| 2019-03-31 | 16.79% |
| 2018-12-31 | 24.50% |
| 2018-09-30 | 9.22% |
| 2018-06-30 | -2.98% |
| 2018-03-31 | 20.08% |
| 2017-12-31 | -4.43% |
| 2017-09-30 | -10.86% |
| 2017-06-30 | -30.95% |
| 2017-03-31 | 19.39% |
| 2016-12-31 | -3.69% |
| 2016-09-30 | -1.16% |
| 2016-06-30 | -20.03% |
| 2016-03-31 | -6.85% |
| 2015-12-31 | -0.72% |
| 2015-09-30 | -1.63% |
| 2015-06-30 | -25.61% |
| 2015-03-31 | 6.51% |
| 2014-12-31 | 11.18% |
| 2014-09-30 | -14.12% |
| 2014-06-30 | -21.94% |
| 2014-03-31 | -3.24% |
| 2013-12-31 | 2.27% |
| 2013-09-30 | -13.00% |
| 2013-06-30 | -5.91% |
| 2013-03-31 | 19.95% |
| 2012-12-31 | 16.21% |
| 2012-09-30 | -2.05% |
| 2012-06-30 | -10.12% |
| 2012-03-31 | 0.13% |
| 2011-12-31 | 2.50% |
| 2011-09-30 | -3.36% |
| 2011-06-30 | -13.30% |
| 2011-03-31 | 19.21% |
| 2010-12-31 | -1.34% |
| 2010-09-30 | -20.77% |
| 2010-06-30 | -9.86% |
| 2010-03-31 | -8.87% |
| 2009-12-31 | 30.19% |
| 2009-09-30 | 26.61% |
| 2009-06-30 | 2.58% |
| 2009-03-31 | -16.58% |
| 2008-12-31 | 18.13% |
| 2008-09-30 | 14.88% |
| 2008-06-30 | -2.34% |
| 2008-03-31 | 20.92% |
| 2007-12-31 | 21.34% |
| 2007-09-30 | 8.78% |
| 2007-06-30 | -9.21% |
| 2007-03-31 | 14.20% |
| 2006-12-31 | 47.19% |
| 2006-09-30 | 9.03% |
| 2006-06-30 | -24.58% |
| 2006-03-31 | 19.70% |
| 2005-12-31 | 27.61% |
| 2005-09-30 | 3.49% |
| 2005-06-30 | -11.54% |
| 2005-03-31 | -78.76% |
| 2004-12-31 | -2.11% |
| 2004-09-30 | -25.76% |
| 2004-06-30 | -16.03% |
| 2004-03-31 | 1.48% |
| 2003-12-31 | 56.63% |
| 2003-09-30 | -2.58% |
| 2003-06-30 | -1.94% |
| 2003-03-31 | 6.93% |
| 2002-12-31 | 2.49% |
| 2002-09-30 | -8.20% |
